Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Profit After Tax (2018 - 2026)

Profound Medical has reported Profit After Tax over the past 8 years, most recently at -$8.2 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 65.25% year-over-year to -$8.2 million; the TTM value through Dec 2025 reached -$42.6 million, down 53.05%, while the annual FY2025 figure was -$42.6 million, 53.04% down from the prior year.
  • Profit After Tax for Q4 2025 was -$8.2 million at Profound Medical, down from -$8.0 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $22.4 million in Q2 2022 and troughed at -$51.2 million in Q4 2021.
  • A 5-year average of -$6.8 million and a median of -$7.2 million in 2021 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: surged 182.06% in 2023 and later tumbled 667.92% in 2024.
  • Year by year, Profit After Tax stood at -$51.2 million in 2021, then increased by 6.69% to -$47.8 million in 2022, then surged by 81.88% to -$8.7 million in 2023, then soared by 42.9% to -$4.9 million in 2024, then plummeted by 65.25% to -$8.2 million in 2025.
  • Business Quant data shows Profit After Tax for PROF at -$8.2 million in Q4 2025, -$8.0 million in Q3 2025, and -$15.7 million in Q2 2025.